rofecoxib has been researched along with Primary Peritonitis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " This effect was prevented by rofecoxib treatment indicating the sensitivity of the model for pelvic pain related to peritonitis." | 3.80 | Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the rat. ( Gruen, M; Laux-Biehlmann, A; Nagel, J; Zollner, TM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gruen, M | 1 |
| Laux-Biehlmann, A | 1 |
| Zollner, TM | 1 |
| Nagel, J | 1 |
1 other study available for rofecoxib and Primary Peritonitis
| Article | Year |
|---|---|
Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the rat.
Topics: Abdominal Pain; Analysis of Variance; Animals; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Mo | 2014 |